# Provision of Bordetella-Free Baboons for Pertussis Infection and Vaccination Studies

Canonical: https://abierto.us/opportunities/75f40126q00204

- Solicitation number: 75F40126Q00204
- Notice type: Combined synopsis and solicitation
- Status: Closed. Deadline was July 10, 2026 at 2:00 PM EDT
- Department: Department of Health and Human Services
- Agency: Food and Drug Administration
- Contracting office: Food and Drug Administration (75F402)
- NAICS: 112990 All Other Animal Production
- Product or service code: 8820 Live Animals, Not Raised for Food
- Place of performance: Silver Spring, Maryland
- First posted: June 25, 2026
- Last posted: June 29, 2026
- SAM.gov: https://sam.gov/workspace/contract/opp/a3a0d837a54747d39a3893ac8c767908/view

## Description

6/29/2026; See attached amendment 1 to the combined synopsis/solicitation. Pertussis is an acute, highly contagious, potentially life-threatening respiratory disease, caused by the Gram-negative bacterium Bordetella pertussis. The underlying factors leading to the failure of public health measures to control pertussis disease using currently licensed vaccines are poorly understood. A more complete understanding of this disease and of the mechanisms of vaccine-mediated protection is a critical public health need.

The baboon model of pertussis, developed in the laboratories of the Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER), is the only animal model of pertussis that recapitulates the disease as observed in human patients.

Refinement of the baboon model to include establishment of infection by means of natural transmission will enable a more refine evaluation of the differences between the licensed acellular pertussis vaccines that fail to prevent infection and the whole cell vaccines that reduce infection. The performance of this study requires the purchase and delivery of twenty, Bordetella-free baboons.

## Publications

- June 25, 2026: Combined synopsis and solicitation, due July 10, 2026 at 2:00 PM EDT. Notice fa39d7200d044035b21a363f765ea651. https://sam.gov/workspace/contract/opp/fa39d7200d044035b21a363f765ea651/view
- June 29, 2026: Combined synopsis and solicitation, due July 10, 2026 at 2:00 PM EDT. Notice a3a0d837a54747d39a3893ac8c767908. https://sam.gov/workspace/contract/opp/a3a0d837a54747d39a3893ac8c767908/view

## Points of contact

- David Kramer, david.kramer@fda.hhs.gov
- Nick Sartain, nick.sartain@fda.hhs.gov

---
Source: SAM.gov Contract Opportunities bulk extract. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/75f40126q00204.